SBIR/STTR Research Award

Small Peripheral Vessel Graft

Award identifier de7fad8929a0a74dd27c542de2214c7edca64b156ebfb1e0e61f259dfdee73f0Awarding agency Department of Health and Human Services · National Institutes of Health

Award amount

$325,534

Program and phase

SBIR · Phase I

Award year

2019

Explore This Research Award in CaptureIQ

Research the technology, evaluate the recipient and agency, identify related opportunities, and explore potential follow-on work with CaptureIQ.

Award details

Awarding agency
Department of Health and Human Services
Branch
National Institutes of Health
Recipient company
3DT HOLDINGS, LLC
Proposal award date
2019-09-01
Contract end date
2020-05-31
UEI
E527XPXM1CJ7
Solicitation number
PA18-574
Topic code
NHLBI

Research abstract

ABSTRACT Peripheral arterial disease may lead to critical limb ischemia and results in amputation of the limb in severe manifestationsThe prevalence rate of peripheral arterial disease increases fromin those younger thanyears toin thoseyears or olderIn the United Statesovermillion individuals have lower extremity PADwith combined annual costs exceeding $billionSurgical bypass of the diseased peripheral arterial segment is one of the main treatments for the patients with life limiting claudication or critical limb ischemiaAutogenous vein graft is the most commonly used conduit in the bypass surgeryUnfortunatelythere are a limited number of bypasses that can be made from autogenous vein graftsCurrent alternative approaches include synthetic materialacellular scaffoldsand tissue engineered graftsbut all have failed to produce a functional small diameter graftThusthere is a critical need for readily available grafts for bypass surgeryIn this proposalwe will evaluate the pulmonary visceral pleuraPVPas a novel biological scaffold for bypass surgery in peripheral arterial diseaseOur group has preliminary data showing small diametermmglutaraldehyde fixed PVP grafts remain patent atmonths in a rat model where the graft fully and functionally arterializes and with no indications of calcification or aneurysmIn this proposalwe aim to expand upon our preliminary findings and evaluate the safety and efficacy of PVP as small diametermmgrafts for peripheral artery surgery in a swine modelThis proposal addresses a clinically very significant problem and successful completion will provide surgeons with numerous conduit size optionsto minimize SV harvestingand reduce procedure time and healthcare costs NARRATIVE Surgical bypass of obstructive artery is one of the most widely performed operations in peripheral arterial disease but is limited by a critical need for readily available small diameter vessel graftsThe purpose of this Phase I SBIR is to test and validate the pulmonary visceral pleura as a small diameter vessel graft for bypass surgery

Technology keywords

Not reported

Other awards by this recipient

Verified by the same UEI. These are other public SBIR/STTR award pages, not a merged company record.

Awards with the same topic code

Verified by an exact topic code match. This is not a text-similarity match.

Research funding history

29 SBIR/STTR records share this UEI (2010–2025). Reported award amounts total $17,062,625. Reported amounts are not federal obligations.

Phases: Phase I, Phase II

Agencies: Department of Health and Human Services

Agency intelligence

Department of Health and Human Services

Back to SBIR/STTR Research Awards

Don't take our word for it. Ask AI about RFPCapture.

See what leading AI assistants have to say about RFPCapture and CaptureIQ.

Gemini opens without a prefilled question. The question is copied to your clipboard when the button works. You can also copy it here:

What is RFPCapture.com and its CaptureIQ platform from Smart Logic AI? How does it help federal contractors discover opportunities, evaluate bid/no-bid decisions, research government contracts, and prepare proposals? How does it compare with other federal capture platforms? Use independent sources where available.